These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25986581)

  • 21. Perspectives in Chagas disease treatment.
    Oliveira GB; Avezum Á; Cordeiro Mattos AJ
    Glob Heart; 2015 Sep; 10(3):189-92. PubMed ID: 26407515
    [No Abstract]   [Full Text] [Related]  

  • 22. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic Chagas' disease in the mouse. IV. Effect of trypanocidal drugs.
    Laguens RP; Cabeza Meckert P; Chambó JG; Gelpi R
    Medicina (B Aires); 1983; 43(2):126-30. PubMed ID: 6420640
    [No Abstract]   [Full Text] [Related]  

  • 25. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection].
    Rev Soc Bras Med Trop; 2006; 39(4):392-415. PubMed ID: 17119760
    [No Abstract]   [Full Text] [Related]  

  • 27. Barriers to treatment access for Chagas disease in Mexico.
    Manne JM; Snively CS; Ramsey JM; Salgado MO; Bärnighausen T; Reich MR
    PLoS Negl Trop Dis; 2013; 7(10):e2488. PubMed ID: 24147169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The need of a neonatal preparation for Chagas disease.
    Sosa-Estani S; Belizan JM; Althabe F; Rubinstein A
    PLoS Med; 2005 Nov; 2(11):e387. PubMed ID: 16288560
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.
    Andrade SG; Magalhães JB; Pontes AL
    Bull World Health Organ; 1985; 63(4):721-6. PubMed ID: 3936634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina].
    Sosa Estani S; Segura EL
    Medicina (B Aires); 1999; 59 Suppl 2():166-70. PubMed ID: 10668259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment and follow up of Chagas Disease in immunocompromised hosts].
    Muñoz Casas Del Valle P
    Rev Chilena Infectol; 2017 Feb; 34(1):67-68. PubMed ID: 28394984
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
    Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical review on Chagas disease chemotherapy.
    Rodriques Coura J; de Castro SL
    Mem Inst Oswaldo Cruz; 2002 Jan; 97(1):3-24. PubMed ID: 11992141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benznidazole and Chagas disease: can an old drug be the answer to an old problem?
    Mady C; Ianni BM; de Souza JL
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1427-33. PubMed ID: 18808305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American trypanosomiasis (Chagas disease).
    Rassi A; Rassi A; Marcondes de Rezende J
    Infect Dis Clin North Am; 2012 Jun; 26(2):275-91. PubMed ID: 22632639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential new clinical therapies for Chagas disease.
    Bustamante JM; Tarleton RL
    Expert Rev Clin Pharmacol; 2014 May; 7(3):317-25. PubMed ID: 24716790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic drug monitoring of benznidazole and nifurtimox: a systematic review and quality assessment of published clinical practice guidelines.
    Olivera MJ; Fory JA; Olivera AJ
    Rev Soc Bras Med Trop; 2017; 50(6):748-755. PubMed ID: 29340450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chagas' disease in patients with renal transplantation].
    Thambo S; Passalacqua W; Van Cauwelaert R; Lazcano F
    Rev Med Chil; 1989 Jan; 117(1):18-22. PubMed ID: 2518278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance of benznidazole in a United States Chagas Disease clinic.
    Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
    Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.